Literature DB >> 11129475

Interim analysis and sample size reassessment.

M Posch1, P Bauer.   

Abstract

This article deals with sample size reassessment for adaptive two-stage designs based on conditional power arguments utilizing the variability observed at the first stage. Fisher's product test for the p-values from the disjoint samples at the two stages is considered in detail for the comparison of the means of two normal populations. We show that stopping rules allowing for the early acceptance of the null hypothesis that are optimal with respect to the average sample size may lead to a severe decrease of the overall power if the sample size is a priori underestimated. This problem can be overcome by choosing designs with low probabilities of early acceptance or by midtrial adaptations of the early acceptance boundary using the variability observed in the first stage. This modified procedure is negligibly anticonservative and preserves the power.

Mesh:

Year:  2000        PMID: 11129475     DOI: 10.1111/j.0006-341x.2000.01170.x

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  4 in total

Review 1.  Modelling and simulation in the development and use of anti-cancer agents: an underused tool?

Authors:  Ferdinand Rombout; Leon Aarons; Mats Karlsson; Anthony Man; France Mentré; Peter Nygren; Amy Racine; Hans Schaefer; Jean-Louis Steimer; Iñaki Troconiz; Achiel van Peer
Journal:  J Pharmacokinet Pharmacodyn       Date:  2004-12       Impact factor: 2.745

2.  Options and Considerations for Adaptive Laboratory Experiments.

Authors:  Lai Wei; David Jarjoura
Journal:  Stat Biosci       Date:  2014-11-25

3.  Sample size re-estimation without un-blinding for time-to-event outcomes in oncology clinical trials.

Authors:  Li-hong Huang; Jian-ling Bai; Hao Yu; Feng Chen
Journal:  J Biomed Res       Date:  2017-06-20

4.  Effectiveness of using a new polyurethane foam multi-layer dressing in the sacral area to prevent the onset of pressure ulcer in the elderly with hip fractures: A pragmatic randomised controlled trial.

Authors:  Cristiana Forni; Fabio D'Alessandro; Pina Gallerani; Rossana Genco; Andrea Bolzon; Caterina Bombino; Sandra Mini; Laura Rocchegiani; Teresa Notarnicola; Arianna Vitulli; Alfredo Amodeo; Guglielmo Celli; Patrizia Taddia
Journal:  Int Wound J       Date:  2018-01-04       Impact factor: 3.315

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.